About Outset Medical
Outset Medical is a company based in San Jose (United States) founded in 2003. Outset Medical has raised $467.37 million across 10 funding rounds from investors including Fidelity Investments, T. Rowe Price and Baxter. Outset Medical offers products and services including Tablo Hemodialysis System. Outset Medical operates in a competitive market with competitors including Fresenius, Hemotune, Diality, NxStage and Chongqing Shanwaishan Blood Purification Technology, among others.
- Headquarter San Jose, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Outset Medical, Inc.
-
Annual Revenue
$113.69 M (USD)-12.8as on Dec 31, 2024
-
Net Profit
-$127.98 M (USD)25.94as on Dec 31, 2024
-
EBITDA
-$102.09 M (USD)37.73as on Dec 31, 2024
-
Total Equity Funding
$467.37 M (USD)
in 10 rounds
-
Latest Funding Round
$3.89 M (USD), Post-IPO
Jan 03, 2025
-
Investors
Fidelity Investments
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Outset Medical
Outset Medical is a publicly listed company on the NASDAQ with ticker symbol OM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Outset Medical
Outset Medical offers a comprehensive portfolio of products and services, including Tablo Hemodialysis System.
All-in-one system for hemodialysis treatments in hospitals and homes.
People of Outset Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Outset Medical
Outset Medical has successfully raised a total of $467.37M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3.89 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Outset Medical
Outset Medical has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, T. Rowe Price and Baxter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Healthcare companies are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked |
Investor details for Outset Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Outset Medical
Investment portfolio details for Outset Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Outset Medical
Detailed financials for Outset Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Outset Medical Comparisons
Peer comparison for Outset Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Outset Medical
Outset Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fresenius, Hemotune, Diality, NxStage and Chongqing Shanwaishan Blood Purification Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
System-critical products and services for healthcare therapies are provided.
|
|
| Locked | Locked | Locked |
Developer of a device for blood purification
|
|
| Locked | Locked | Locked |
Developer of portable hemodialysis device
|
|
| Locked | Locked | Locked |
Home and critical care dialysis systems
|
|
| Locked | Locked | Locked |
Blood purification equipment for kidney failure patients is provided.
|
Detailed competitors of Outset Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Outset Medical
Complete news archive for Outset Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Outset Medical
Outset Medical was founded in 2003 and raised its 1st funding round 8 years after it was founded.
Outset Medical is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Outset Medical is a funded company, having raised a total of $467.37M across 10 funding rounds to date.
Annual revenue of Outset Medical is $113.69M as on Dec 31, 2024.
Outset Medical was established in 2003 in San Jose, United States, within the medical device sector. Hemodialysis solutions are developed and supplied by the company, with the Tablo system serving as the primary product. This machine incorporates a touchscreen interface that delivers step-by-step visual guidance and interactive prompts to facilitate dialysis procedures. Operations emphasize equipment for renal care, distributed across healthcare facilities in the region.
Outset Medical offers Tablo Hemodialysis System.
Yes, Outset Medical is publicly traded on NASDAQ under the ticker symbol OM.
Outset Medical has 9 investors. Key investors include Fidelity Investments, T. Rowe Price, Baxter, Mubadala, and Warburg Pincus.
The ticker symbol of Outset Medical is OM on NASDAQ.